Evidence map›Paper›PMID 37510958›Full record

ArticleJournal of clinical medicine2023

Clinical Features, Biochemical Parameters, and Treatment Adherence of Individuals Who Started the Treatment for Active Pulmonary Tuberculosis during the Pandemic Period.

Amanda Caroline de Souza Sales, Larissa Araújo Lopes, Maria Caroliny Dos Santos Vale, Mayara Ferreira Costa, João Victor de Souza Lima, João Gabriel Matos da Silva, Bruna Sthefanny da Cunha Ferreira, Victoria Alves do Nascimento, Saara Emanuele da Silva Flor, Elane Luiza Costa de Sousa and 6 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Amanda Caroline de Souza SalesLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.
Larissa Araújo LopesLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.
Maria Caroliny Dos Santos ValeLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.
Mayara Ferreira CostaLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.
João Victor de Souza LimaLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.
João Gabriel Matos da SilvaLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.
Bruna Sthefanny da Cunha FerreiraLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.
Victoria Alves do NascimentoLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.
Saara Emanuele da Silva FlorLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.
Elane Luiza Costa de SousaLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.
Bruna Katarine Bezerra PazLaboratory of Clinical Analysis (LABORCEUMA), CEUMA University, São Luís 65075-120, MA, Brazil.
Ricardo Amorim de Sousa GarciaPostgraduate Program in Health and Services Management, CEUMA University, São Luís 65075-120, MA, Brazil.
Eduardo Martins de SousaPostgraduate Program in Microbial Biology, CEUMA University, São Luís 65075-120, MA, Brazil.
Alexsandro Ferreira Dos SantosDepartament of Nutrition, CEUMA University, São Luís 65075-120, MA, Brazil.
Luís Cláudio Nascimento da SilvaLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.ORCID 0000-0002-4206-0904
Adrielle ZagmignanLaboratory of Microbial Pathogenesis, CEUMA University, São Luís 65075-120, MA, Brazil.ORCID 0000-0001-9865-2223
Universidade Ceuma · BR

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88881.510197/2020-01Fundação de Amparo à Pesquisa e ao Desenvolvimento Científico e Tecnológico do Maranhão PPSUS-02113/20; POS-GRAD-02460/21; INFRA-02032/21
6 · The paper itself

Abstract

This descriptive prospective study investigated the clinical features and treatment adherence of individuals who started the treatment for Pulmonary tuberculosis (TB) during the COVID-19 pandemic in São Luís. Thirty-six TB patients and thirty-five age/sex-matched individuals were recruited between January 2021 and January 2022. The clinical features, sociodemographic information, and serum were obtained at the diagnosis time. Adherence to treatment and adverse reactions were investigated monthly. The most common symptoms in TB patients were cough (91.6%) and fever (83.3%). All TB patients had elevated pre-therapy levels of CRP and reduced HDL: 88.9% presented hypocalcemia and 47.2% showed elevated ALP and GGT. TB patients showed higher levels of ALT, AST, ALP, GGT, CRP, amylase, and triglycerides than the comparison group (

Indexed as

adverse drug reactionsbacterial infectionsbiochemical markers

Identifiers

PMID37510958
PMCPMC10381187
OpenAlexW4385221214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.